High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy
Open Access
- 1 March 1997
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 56 (3) , 167-172
- https://doi.org/10.1136/ard.56.3.167
Abstract
OBJECTIVE A high seroprevalence of HTLV-I in female Sjögren’s syndrome (SS) patients has been reported in Nagasaki, Japan, an area that is heavily endemic for HTLV-I infection. Salivary IgA class antibodies to HTLV-I were common among HTLV-I seropositive patients with SS. This study was undertaken to elucidate the pathogenesis of SS caused by HTLV-I infection. METHODS The clinical features and histological findings of SS and the prevalence of serum autoantibodies in 10 patients with HTLV-I associated myelopathy (HAM) who were consecutively admitted into Nagasaki University School of Medicine, were compared with those of 20 HTLV-I seropositive and 20 HTLV-I seronegative patients with SS. RESULTS Ocular and oral manifestations of SS were commonly detected in HAM patients. These patients also had extraglandular manifestations including recurrent uveitis, arthropathy, interstitial pneumonitis, Raynaud’s phenomenon, and inflammatory bowel disease. All patients with HAM histologically showed a mononuclear cell infiltration in the labial salivary grands. Six of 10 patients had a mononuclear cell infiltration with a focus score of 1 or greater. According to the preliminary criteria for SS proposed by the European Community, definitive SS was diagnosed in six patients and probable SS in two patients. Serum γ globulin and IgG values were increased in HAM patients. Patients with HAM had lower prevalence of rheumatoid factor, anti-nuclear antibody, and anti-SS-A (Ro) antibody than those of HTLV-I seropositive and HTLV-I seronegative SS patients. However, there was no significant difference in the prevalence of these antibodies among HAM patients with definitive SS, HTLV-I seropositive and HTLV-I seronegative SS patients. The CD3+CD4+ T cells preferentially infiltrated into the salivary glands in HAM patients as well as the salivary glands of patients with HTLV-I seropositive and seronegative patients. It seems probable that peripheral blood mononuclear cells from HAM patients preferentially infiltrated into the salivary glands, and that these cells produced the autoantibodies as well as anti-HTLV-I antibody. CONCLUSION The results strongly support the idea that HTLV-I is involved in the pathogenesis of the disease in a subset of patients with SS in endemic areas.Keywords
This publication has 33 references indexed in Scilit:
- Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses.Annals of the Rheumatic Diseases, 1995
- Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndromeThe Lancet, 1994
- Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European communityArthritis & Rheumatism, 1993
- Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.Annals of the Rheumatic Diseases, 1992
- Increased replication of HTLV‐I in HTLV‐I–associated myelopathyAnnals of Neurology, 1989
- Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cellsAnnals of Neurology, 1987
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.Proceedings of the National Academy of Sciences, 1981
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980
- GUY'S HOSPITAL.The Lancet, 1824